Friday, 22 August 2014
Last updated 5 hours ago
Mar 17 2014 | 7:37am ET
Hedge funds added 2.46% in February, according to the Hennessee Hedge Fund Index, trailing the 4.31% gain of the S&P 500.
The top performing strategies for the month were healthcare and biotech, up 4.14%; distressed, up 3.72%; and international, up 3.29%
The bottom three strategies for the month were short biased, down 2.34%; market neutral, down 0.02%; and convertible arbitrage, up 0.19%.
“Risk assets reversed course again in February as volatility, measured by the VIX, subsided and market enthusiasm was restored,” said Charles Gradante, Hennessee Group co-founder, in a statement. "Investors stepped back into the market after January’s selloff and shrugged off disappointing European PMI data, a continued decrease in bank lending and emerging market tensions.”
Equity long/short hedge funds were up 2.81% in February (3.13% year to date), arbitrage event/driven strategies were up 1.83% (2.50% YTD) and merger arbitrage strategies were up 1.81% (2.04% YTD).
Global macro funds gained 2.53% in February (0.47% YTD). Emerging funds were up 2.14% on the month (down 0.20% YTD). Macro funds rose 2.65% for the month of February (0.83% YTD).
Aug 4 2014 | 7:42am ET
By now, U.S. and international subscribers have received their home or office delivery of the special 500th issue of Futures magazine. You can too!—a very special offer follows. The issue is the largest in years—filled with the best trading strategies and stories from 43 years of being the primary publication for commodity, stock, options and forex traders. Read more…
The July/August 2014 issue is our largest in years—filled with the best trading strategies and stories from 43 years of being the primary publication for commodity, stock, options and forex traders.
The Alpha Pages Editor's Note